Clinical trials
Terminated Carcinoma in Situ trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| Altor BioScience | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Bioniche Life Sciences Inc. | 1 |
| CG Oncology, Inc. | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Rogers, B.H. Gerald, M.D. | 1 |
| University of Pittsburgh | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma in Situ | 10 |
| Urinary Bladder Neoplasms | 7 |
| Carcinoma, Transitional Cell | 6 |
| Neoplasms | 4 |
| Non-Muscle Invasive Bladder Neoplasms | 3 |
| Urinary Bladder Diseases | 3 |
| Neoplasms by Site | 2 |
| Urogenital Neoplasms | 2 |
| Urologic Diseases | 2 |
| Urologic Neoplasms | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.